Is increased intracellular calcium in red blood cells a common component in the molecular mechanism causing anemia? by Hertz, Laura et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Is increased intracellular calcium in red blood cells a common component in
the molecular mechanism causing anemia?
Hertz, Laura; Huisjes, Rick; Llaudet-Planas, Esther; Petkova-Kirova, Polina; Makhro, Asya; Danielczok,
Jens G; Egee, Stephane; Del Mar Mañú-Pereira, Maria; van Wijk, Richard; Vives Corrons, Joan-Lluis;
Bogdanova, Anna; Kaestner, Lars
Abstract: For many hereditary disorders, although the underlying genetic mutation may be known,
the molecular mechanism leading to hemolytic anemia is still unclear and needs further investigation.
Previous studies revealed an increased intracellular Ca(2+) in red blood cells (RBCs) from patients with
sickle cell disease, thalassemia, or Gardos channelopathy. Therefore we analyzed RBCs’ Ca(2+) content
from 35 patients with different types of anemia (16 patients with hereditary spherocytosis, 11 patients with
hereditary xerocytosis, 5 patients with enzymopathies, and 3 patients with hemolytic anemia of unknown
cause). Intracellular Ca(2+) in RBCs was measured by fluorescence microscopy using the fluorescent
Ca(2+) indicator Fluo-4 and subsequent single cell analysis. We found that in RBCs from patients with
hereditary spherocytosis and hereditary xerocytosis the intracellular Ca(2+) levels were significantly
increased compared to healthy control samples. For enzymopathies and hemolytic anemia of unknown
cause the intracellular Ca(2+) levels in RBCs were not significantly different. These results lead us to the
hypothesis that increased Ca(2+) levels in RBCs are a shared component in the mechanism causing an
accelerated clearance of RBCs from the blood stream in channelopathies such as hereditary xerocytosis
and in diseases involving defects of cytoskeletal components like hereditary spherocytosis. Future drug
developments should benefit from targeting Ca(2+) entry mediating molecular players leading to better
therapies for patients.
DOI: https://doi.org/10.3389/fphys.2017.00673
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-140865
Published Version
 
 
Originally published at:
Hertz, Laura; Huisjes, Rick; Llaudet-Planas, Esther; Petkova-Kirova, Polina; Makhro, Asya; Danielczok,
Jens G; Egee, Stephane; Del Mar Mañú-Pereira, Maria; van Wijk, Richard; Vives Corrons, Joan-Lluis;
Bogdanova, Anna; Kaestner, Lars (2017). Is increased intracellular calcium in red blood cells a common
component in the molecular mechanism causing anemia? Frontiers in Physiology, 8:673.
DOI: https://doi.org/10.3389/fphys.2017.00673
PERSPECTIVE
published: 06 September 2017
doi: 10.3389/fphys.2017.00673
Frontiers in Physiology | www.frontiersin.org 1 September 2017 | Volume 8 | Article 673
Edited by:
Mauricio Antonio Retamal,
Universidad del Desarrollo, Chile
Reviewed by:
Fabrice Cognasse,
Scientific Affairs, the
Rhone-Alpes-Auvergne Regional
Branch of the French National Blood
System, France
Mikko Juhani Nikinmaa,
University of Turku, Finland
*Correspondence:
Lars Kaestner
lars_kaestner@me.com
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Membrane Physiology and Membrane
Biophysics,
a section of the journal
Frontiers in Physiology
Received: 21 June 2017
Accepted: 23 August 2017
Published: 06 September 2017
Citation:
Hertz L, Huisjes R, Llaudet-Planas E,
Petkova-Kirova P, Makhro A,
Danielczok JG, Egee S, del Mar
Mañú-Pereira M, van Wijk R, Vives
Corrons J-L, Bogdanova A and
Kaestner L (2017) Is Increased
Intracellular Calcium in Red Blood
Cells a Common Component in the
Molecular Mechanism Causing
Anemia? Front. Physiol. 8:673.
doi: 10.3389/fphys.2017.00673
Is Increased Intracellular Calcium in
Red Blood Cells a Common
Component in the Molecular
Mechanism Causing Anemia?
Laura Hertz 1†, Rick Huisjes 2†, Esther Llaudet-Planas 3, Polina Petkova-Kirova 1,
Asya Makhro 4, Jens G. Danielczok 1, Stephane Egee 5, 6, 7, Maria del Mar Mañú-Pereira 3,
Richard van Wijk 2, Joan-Lluis Vives Corrons 3, Anna Bogdanova 4 and Lars Kaestner 8, 9*
1 Research Centre for Molecular Imaging and Screening, Medical School, Saarland University, Homburg, Germany,
2Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, Netherlands, 3 Red Blood
Cell Defects and Hematopoietic Disorders Unit, Josep Carreras Leukaemia Research Institute, Barcelona, Spain, 4 Red Blood
Cell Research Group, Institute of Veterinary Physiology, Vetsuisse Faculty and the Zurich Center for Integrative Human
Physiology (ZIHP), University of Zurich, Zurich, Switzerland, 5Centre National de la Recherche Scientifique, UMR 8227
Comparative Erythrocyte’s Physiology, Roscoff, France, 6Université Pierre et Marie Curie, Sorbonne Universités, Roscoff,
France, 7 Laboratoire d’Excellence GR-Ex, Roscoff, France, 8 Theoretical Medicine and Biosciences, Saarland University,
Homburg, Germany, 9 Experimental Physics, Saarland University, Saarbruecken, Germany
For many hereditary disorders, although the underlying genetic mutation may be
known, the molecular mechanism leading to hemolytic anemia is still unclear and
needs further investigation. Previous studies revealed an increased intracellular Ca2+ in
red blood cells (RBCs) from patients with sickle cell disease, thalassemia, or Gardos
channelopathy. Therefore we analyzed RBCs’ Ca2+ content from 35 patients with
different types of anemia (16 patients with hereditary spherocytosis, 11 patients with
hereditary xerocytosis, 5 patients with enzymopathies, and 3 patients with hemolytic
anemia of unknown cause). Intracellular Ca2+ in RBCs was measured by fluorescence
microscopy using the fluorescent Ca2+ indicator Fluo-4 and subsequent single cell
analysis. We found that in RBCs from patients with hereditary spherocytosis and
hereditary xerocytosis the intracellular Ca2+ levels were significantly increased compared
to healthy control samples. For enzymopathies and hemolytic anemia of unknown cause
the intracellular Ca2+ levels in RBCs were not significantly different. These results lead
us to the hypothesis that increased Ca2+ levels in RBCs are a shared component in
the mechanism causing an accelerated clearance of RBCs from the blood stream in
channelopathies such as hereditary xerocytosis and in diseases involving defects of
cytoskeletal components like hereditary spherocytosis. Future drug developments should
benefit from targeting Ca2+ entry mediating molecular players leading to better therapies
for patients.
Keywords: rare anemia, erythrocyte, calcium homeostasis, channelopathies, live cell imaging, spherocytosis,
xerocytosis
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INTRODUCTION
Anemia, defined as a hemoglobin concentration <11–13 g/dl,
based on gender and age, affects 1.6 billion people worldwide
(McLean et al., 2009). About 10% of these individuals are affected
by rare anemias. This disease group includes ∼90 different types
of red blood cell (RBC) diseases, of which 80% are hereditary or
congenital in nature. As the pathophysiology of most of these rare
anemias is poorly understood, the appropriate treatment is often
ineffective or even lacking.
Anemia in general has three major causes: blood loss,
insufficient hematopoiesis, or facilitated removal of RBCs from
the blood stream (Ossendorf, 2003). In hemolytic anemias the
RBC premature clearance and shortened lifespan of RBCs are not
compensated by enhanced RBC production giving rise to anemia
(Dhaliwal et al., 2004). Many types of anemia can be assigned to
mutations in a single protein. However, it is still unclear how
these mutations transfer into an increased clearance of RBCs
and what defines heterogeneity in disease severity. A prominent
example is sickle cell disease. Described as a molecular disease as
early as 1949 (Pauling et al., 1949), sickle cell disease is caused by
a single point mutation in the ß-globin gene (Ingram, 1958). The
mutated hemoglobin variant, HbS, is prone to polymerization
and formation of HbS aggregates, that are even more likely to
occur upon dehydration of RBCs (Layton and Nagel, 2010).
Dehydration is largely mediated by high intracellular Ca2+,
subsequent activation of Gardos Channels and loss of K+ (Lew
et al., 2002). Ca2+ uptake in sickle RBCs is abnormally high,
and not always compensated by Ca2+ extrusion by the Ca2+
pumps resulting in an elevated intracellular Ca2+ content (Eaton
et al., 1973; Tiffert et al., 2003). This increase in the Ca2+ content
is attributed to highly abundant hyperactive NMDA receptors
in membranes of patients’ RBCs. Inhibition of Ca2+ uptake
via these receptors could prevent dehydration and sickling of
RBCs in vitro (Hänggi et al., 2014; Bogdanova et al., 2015).
However, it remains elusive, how themutation in the hemoglobin
“causes” the increased Ca2+-influx. The fact that vaso-occlusive
crises in sickle cell disease patients occur sporadically (Rieber
et al., 1977) points to a rather indirect connection. Increased
intracellular Ca2+ levels were also found in RBCs from, e.g.,
beta thalassemia patients (Bookchin et al., 1988) or patients
with Gardos channelopathy (Fermo et al., 2017). It is known
that Ca2+ overload triggers several downstream events in RBCs
(Bogdanova et al., 2013). One important effect is the impairment
of the cytoskeletal stability, e.g., through activation of calpain and
subsequent cleavage of membrane associated proteins (Inomata
et al., 1993; Salamino et al., 1993). The activation of calmodulin
and its interaction with the band 4.1R protein has been shown
to decrease the affinity of 4.1R for its cytoskeletal interaction
partners actin and spectrin and thereby loosening the cytoskeletal
structure (Jarret and Kyte, 1979; Nunomura and Takakuwa,
2006). A decreased RBC volume is resulting from the Ca2+
dependent opening of the Gardos channel, which leads to loss of
K+, Cl− and water (Gardos, 1958). Furthermore, increased Ca2+
levels lead to the disruption of the asymmetrical distribution of
phospholipids in the plasma membrane. Phosphatidylserine, a
lipid exclusively present in the inner leaflet of the membrane,
becomes exposed on the outer membrane by activation of the
scramblase and simultaneous inhibition of the flippase (Verkleij
et al., 1973; Bitbol et al., 1987; Bassé et al., 1996; Woon et al.,
1999). All these described changes in the cell physiology as
well as the increased Ca2+ are signs of senescence (sometimes
referred to as eryptosis) and prime the cells for clearance from
the blood stream (Lutz and Bogdanova, 2013). A substantial
increase in intracellular Ca2+ also increases the osmotic fragility
with no strict correlation to cell volume and largely before cells
reach spherocytic hemolysis volume (Cueff et al., 2010). This
might be an additional mechanism of a decrease in RBC number
associated to an elevated Ca2+concentration. To what extent a
Ca2+ induced increased vesiculation (Nguyen et al., 2011; Alaarg
et al., 2013) may alter the RBC clearance is still unknown.
Here we aim to investigate if elevated intracellular Ca2+ levels
are a general feature in the pathophysiology of hemolytic anemia
and such provides a mechanistic link for an increased clearance
of RBCs resulting in anemia of hemolytic patients.
MATERIALS AND METHODS
Participants
Patients diagnosed with different types of anemia were enrolled
in the study after signed informed consent. Patient data were
handled anonymously as outlined in the ethics applications.
These applications were approved by the Medical Ethical
Research Board (MERB) of the University Medical Center
Utrecht, the Netherlands, (UMCU) under reference code
15/426M “Disturbed ion homeostasis in hereditary hemolytic
anemia” and also by the Ethical Committee of Clinical
Investigations of Hospital Clinic, Spain, (IDIBAPS) under the
reference code 2013/8436. Exclusion criteria were erythrocyte
transfusion in the past 90 days, age below 3 years and/or body
weight lower than 18 kg. Blood from healthy control donors
was anonymously obtained using the approved medical ethical
protocol of 07/125 Mini Donor Dienst, also approved by the
MERB of UMCU. The blood of the patient and the healthy
donor anti-coagulated in lithium-heparin was shipped overnight
from the University Medical Center Utrecht (Utrecht, The
Netherlands) and from Institut d’Investigacions Biomèdiques
August Pi i Sunyer/Hospital Clínic de Barcelona (Barcelona,
Spain) to Saarland University (Homburg, Germany). All patients
included in this study were genetically screened for mutations
by next-generation sequencing and diagnosed with the following
types of anemia: 16 patients included in this study were
diagnosed with hereditary spherocytosis using golden standard
techniques (EMA-binding, osmotic gradient ektacytometry and
osmotic fragility test). Moreover, these 16 patients were screened
for mutations by next-generation sequencing: 7 patients had
mutations in ANK1, 4 patients had mutations in SPTA1, 3
patients in SPTB, and 2 patients showed mutations in SLC4A1).
Eleven patients were diagnosed with hereditary xerocytosis (due
to mutations in PIEZO1), 5 patients had enzymatic disorders (3
patients with glucose-6-phosphate dehydrogenase deficiency, 1
patient with glutamate-cysteine ligase deficiency, 1 patient with
glutathione reductase deficiency) and 3 patients suffered from
hemolytic anemia of unknown cause.
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Calcium Imaging
Ca2+ imaging experiments were carried out with RBCs from 35
patient blood samples and 25 healthy transportation controls.
Intracellular Ca2+ was measured from single cells as Fluo-
4 (Thermo Fisher Scientific, Waltham, MA, USA) based
fluorescence intensity as described before (Wang et al., 2014).
Data Analysis
Analysis of the fluorescence images was performed in ImageJ
(Wayne Rasband, National Institutes of Health) and further
processing of the data was done using Matlab (Mathworks,
Natick, MA, USA) and GraphPad Prism (GraphPad Software
Inc., La Jolla, CA, USA). For each patient and control at least 200
individual cells were analyzed. The mean fluorescence intensity
values were plotted as box-and-whiskers. Boxes showmedian and
25th to 75th percentiles, whiskers are drawn down to 10th and up
to 90th percentile. For cell-based analysis of single patients and
controls, significance was checked using the Mann–Whitney test.
For patient-based analysis, patients were grouped in
hereditary spherocytosis, hereditary xerocytosis, enzymopathies,
and hemolytic anemia of unknown cause. As a statistical
basis we used the median fluorescence intensity value from
the single cell analysis for each patient and control sample.
Intensity values from controls were normalized to their mean
value, whereas patients were normalized to the corresponding
shipping control. Significance was tested on not normalized
raw data using the paired t-test when data showed a normal
distribution (D’Agostino-Pearson normality test) otherwise with
the Wilcoxon signed-rank test.
RESULTS
In this study, 35 patients with different types of hemolytic
anemia were analyzed. Patients were grouped according to
their disease into 4 subgroups: hereditary spherocytosis patients,
hereditary xerocytosis patients, patients with enzymopathies and
patients with unknown hemolytic anemia. For each subgroup,
representative fluorescence images of Fluo-4 loaded RBCs from
patients and corresponding transportation controls of healthy
donors are depicted in Figures 1A–D.
Figures 1E–H show the cell-based statistical analysis for
each patient and the corresponding control. Fluo-4 fluorescence
intensity from single cells was measured and plotted. There was
a huge variation in the intensity-correlated Ca2+ concentrations
when comparing the samples taken altogether. However, when
we compared samples within a particular shipment (identical
transportation conditions), the Ca2+ concentrations were in
a similar/comparable range. Therefore we always compared
patients exclusively to their corresponding shipping controls.
In all 16 cases of hereditary spherocytosis we found that
intracellular Ca2+ levels in RBCs were significantly elevated
in patients compared to the corresponding healthy shipping
control samples (Figure 1E). In hereditary xerocytosis 9 out of 11
patients showed increased Ca2+ levels, whereas for the other two
patients no significant differences could be detected (Figure 1H,
P50.1 and P51.2).
The group of unknown hemolytic anemia patients gave a
more heterogeneous picture. The Ca2+ content in one patient
was significantly increased, whereas the other two patients
had significantly lower Ca2+ levels than the shipping control
(Figure 1F, P30.1 vs. P31.1 and P32.1). The situation was
similar for the enzymopathies: three patients (Figure 1G, P41.1,
P42.1, P43.1) had an increased intracellular Ca2+ content, one
was significantly lower and one patient showed no significant
difference compared to its control (Figure 1G, P44.1 and P40.1,
respectively).
The patient-based statistical analysis of the Ca2+
concentrations is depicted in Figure 2A and shows the paired
and normalized analysis of all patients in comparison to all
controls. Ca2+ levels in hemolytic anemia patients show a highly
significant increase. Figure 2B shows the same analysis for
subgroups of patients. The groups with hereditary spherocytosis
and hereditary xerocytosis patients have significantly increased
levels of intracellular Ca2+, compared to the controls. Patients
with enzymopathies depict an increase in the intracellular Ca2+
concentration but fail to reach significant changes. For patients
with hemolytic anemia of unknown cause intracellular Ca2+
levels appear to be heterogeneous, because it is a non-systematic
group composition.
DISCUSSION
Ca2+ Overload
In this study we monitored the intracellular Ca2+ levels in
RBCs from patients with several types of hemolytic anemia.
We found that in the analyzed cases of membranopathies,
hereditary spherocytosis and hereditary xerocytosis, intracellular
Ca2+ is significantly increased. Figure 2C depicts the proposed
mechanism. Starting with the previously described sickle cell
disease (compare Introduction) an increased number of NMDA
receptors were identified to cause the abnormal uptake of Ca2+
(Hänggi et al., 2014). In vitro, this increase in Ca2+ can be
reduced by NMDA blockers like Memantine and a pilot clinical
trial investigating the effect of this drug on sickle cell disease
patients is closed and the statistical analysis is currently on-going
(Bogdanova et al., 2017). For other types of anemia the Ca2+
entry pathways are rather unclear. In the Gardos channelopathy
it is suggested that Ca2+ enters via the mechanical activated
Piezo1 channel (Fermo et al., 2017). We found several different
mutations for the PIEZO1 gene in the xerocytosis patients
included in our study. A further characterization of how these
mutations affect the physiology of the channel is still ongoing,
but data in the literature show that six dehydrated hereditary
stomatocytosis-causingmutations in the Piezo1 channel with five
of them in the C-terminal 1/5 of the protein, result in a slowing of
the inactivation kinetics of the channel and thus to a more active
channel (Albuisson et al., 2013). However, independent of Ca2+
entry pathways also an impairment of Ca2+ extrusion (of residual
Ca2+ influx) needs to be considered as an important factor for
the Ca2+ homeostasis in RBCs. The plasma membrane Ca2+
ATPase (PMCA) is the only known active extrusion pathway
for Ca2+ in RBCs and its transportation capacity is limited by
the availability of ATP (Schatzmann, 1966; Pasini et al., 2006).
It has been reported that Piezo1 can regulate the ATP release
from human RBCs and that mutations in the channel can alter
the released amount of ATP (Cinar et al., 2015). Therefore it
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FIGURE 1 | Intracellular Ca2+ content in RBCs from patients with different types of hemolytic anemia. (A–D) Representative fluorescence images of Fluo-4 loaded
RBCs from control and patient blood samples. Relative intracellular Ca2+ concentration is scaled from black (lowest) to white (highest). Patients were grouped
according to their disease diagnosis: hereditary spherocytosis (blue), hemolytic anemia (purple), enzymopathies (green), hereditary xerocytosis (orange).
(E–H) Statistical analysis of the mean Fluo-4 intensity values in arbitrary units from single cells for each group of patients and the corresponding control samples.
Controls and patients that belong to the same shipment are highlighted with a white or gray background. Controls are displayed as black boxes, patients are colored
in blue (hereditary spherocytosis), purple (unknown hemolytic anemia), green (enzymopathies), and orange (hereditary xerocytosis). Whiskers indicate the range
between 10th and 90th percentiles. There is a huge variation in the intensity-correlated Ca2+ concentrations already within the control group of healthy donors.
Significance was tested between each patient and the according shipping control sample (always the next control sample on left side) using the Mann–Whitney test
(ns denotes p > 0.5, *p ≤ 0.5, ***p ≤ 0.01).
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FIGURE 2 | Patient-based statistical analysis of intracellular Ca2+ levels and proposed mechanisms. (A) Statistical analysis of normalized median fluorescence
intensity values for all 35 patients (red bar) and 25 healthy shipping controls (black bar). Significance was tested using the Wilcoxon signed-rank test (***p ≤ 0.01). (B)
Statistical analysis of normalized median fluorescence intensity values for controls and patients grouped by disease. Number of control samples differs for each
disease group. Hereditary spherocytosis (blue): 16 patients and 12 controls, hereditary xerocytosis (orange): 12 patients and 5 controls, hemolytic anemia (purple): 3
patients and 3 controls, enzymopathies (green): 5 patients and 5 controls. Significance was tested using the paired t-test, when data showed a Gaussian distribution
(D’Agostino-Pearson normality test), otherwise using the Wilcoxon signed-rank test (ns denotes p > 0.5, ***p ≤ 0.01). (C) Proposed mechanisms leading to increased
intracellular Ca2+ levels in diseased RBCs and accordingly to accelerated clearance of cells from the blood stream. Alternative or cumulating Ca2+ entry pathways
are highlighted with gray background: increased abundance of NMDA-receptors (NMDAR), e.g., in sickle cell disease, altered activity of Piezo1, e.g., in hereditary
xerocytosis, increased activity of Gardos Channel, e.g., in Gardos Channelopathy, or unspecified Ca2+ transport mechanisms. Additionally, ineffective extrusion of
Ca2+ due to disruption of ATP pools fueling the plasma membrane Ca2+ ATPase (PMCA) can contribute. Several downstream processes follow Ca2+ overload in
RBCs, e.g.: activation of calmodulin by formation of the Ca2+-calmodulin complex (Ca-CaM) and activation of calpain, thereby loosening the cytoskeletal structure;
activation of the scramblase (Scr) leading to exposure of phosphatidylserine on the outer leaflet of the membrane; activation of the Gardos channel followed by the
efflux of K+, Cl− and H2O and consecutive cell shrinkage.
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is also possible that the detected Ca2+ overload in RBCs from
xerocytosis patients is due to ATP depletion and ineffective Ca2+
extrusion. This would imply that glycolytic enzyme defects of the
RBC, generally considered to lead to decreased ATP levels, would
result in Ca2+ overload. The ATP needed to fuel the pump is
trapped inmembrane-associated complexes (ATP pools). Among
others, identified components of these complexes are Band 3,
ankyrin, and β-spectrin (Chu et al., 2012). Mutations in these
proteins are found in the spherocytosis patients included in this
study. If these mutations lead to a disruption of the complexes
serving as ATP pools for the Ca2+ pump, the extrusion of
Ca2+ will also be significantly reduced. Likewise, the general
cytoskeleton stability is impaired in RBCs from spherocytosis
patients. Changes in the mechanical stability of the cells
may result in an activation of mechanosensitive channels, like
Piezo1, again leading to an increase in intracellular Ca2+. Both
components (increased Ca2+ leak and decreased Ca2+ extrusion)
could happen independent of each other or even mutually
reinforce.We can exclude that the different values in fluorescence
intensity are due to changes in cell volume: In a different study
we tested volume changes, e.g., by osmotic swelling, and co-
stained RBCs with Calcein Red-Orange, a dye insensitive to
the Ca2+ concentration and intensity changes were negligible
compared to intensity changes occurring in measurements
probing the RBCs Ca2+ concentration (Danielczok et al., 2015).
The delicate balance between Ca2+ entry and exit is likely to
be influenced by mechanical stress. During their journey in the
blood stream, RBCs experience hundreds squeezes when passing
small capillaries and the spleen. To perform such experiments
in artificial circulation systems in vitro became recently available
based onmicrofluidic devices (Brust et al., 2014; Danielczok et al.,
2015; Picot et al., 2015) and should be a future experimental
focus.
The results we report do have a therapeutic impact: they
illustrate that disease specific pharmacological targets should be
upstream of the increase in intracellular Ca2+ to avoid all Ca2+
related effects that accumulate the processes facilitating RBC
clearance as outlined in Figure 2C. In contrast pharmacological
targets downstream of the action of intracellular Ca2+ may fail to
address themajor symptoms of the disease as it was shown for the
Gardos channel inhibitor Senicapoc. In sickle cell disease patients
it failed to improve acute vaso-occlusive crises (Ataga et al., 2011).
Blood Shipment
Having a critical look at our data from Figures 1E–H it is
evident that the transportation process has a huge impact on
the measured intracellular Ca2+ content in RBCs. Differences
(within controls) are mainly not due to different transportation
times (which were similar for all shipments) but to different
transportation conditions, like temperature, vibration intensity
and duration or other shipment related parameters that are
out of our control. We choose Heparin as an anticoagulant
because it does not interfere with the extracellular Ca2+.
Other standard anticoagulants like CPDA or EDTA bind the
external Ca2+, making internal Ca2+ measurements unreliable
(Makhro et al., 2016). In the mentioned study transportation
was simulated under laboratory conditions, which shows better
results than the inconsistency of control samples within the
present experiments (Figures 1E–H). In addition we do not
know if intracellular Ca2+ levels during transportation are
more severely influenced in patient RBCs compared to healthy
controls, which presents an uncertainty of this study. Therefore
future studies require investigations without cellular convolution
by the shipment process, i.e., either a travel of the patient
to specialized laboratories for single cell investigations or the
establishment of such specialized mobile laboratories.
CONCLUSION
Considering our Ca2+ data and the results from studies on sickle
cells and RBCs from patients with Gardos channelopathies, there
is strong evidence that the Ca2+ overload in RBCs contributes to
their accelerated clearance from the circulation and is a common
part of the molecular mechanism in these types of anemia.
The exact molecular regulation of the Ca2+ entry pathways
requires further investigations. Future drug developments should
benefit from targeting Ca2+ entry mediating molecular players,
as, e.g., Memantine for the treatment of sickle cell disease patients
(Bogdanova et al., 2017), leading to better therapies for patients.
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